SlideShare a Scribd company logo
Do’s and Don’t’s in the
management of intestinal
fistulae
St. Petersburg, Russia
Peter B. Soeters
the Netherlands
Enterocutaneous fistula
• Abnormal communication between the intestinal tract and the skin
or a hollow organ
• Mrs. Van der G., 62 years old, 1.68 m, 58 kg
• no serious comorbidity, admitted to the emergency ward
elsewhere
• abdominal pain for 3 days, vomiting and no passage of
stools since three days, no fever.
• Medical history
• Hysterectomy (removal of the uterus) 20 years earlier
because of uncontrollable meno-, metrorhagies (bleeding).
• Since years recurrent crampy pain and slight bowel
distention with audible bowel sounds. This has been
become worse and at times she has been anorectic.
• Physical examination
• Slight distension of the abdomen, no bowel sounds
• Tenderness and rebound tenderness in the abdomen but
especially in the left upper quadrant .
• Clinically dehydrated.
• Plain X-ray films of the abdomen in standing position:
X- abdomen confirms
the diagnosis small
bowel obstruction
P.o. day -2 y to -9
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol
N ± 7.3 – 8
7,1
Leuco’s/fl 23
Alb g/L
N ± 40
31
Kreat µM/L
N ± 80
153
BW kg 66-58 60
• Is the Hb normal?
• Is she malnourished?
What is Malnutrition?
A nutritional state resulting from a
combination of varying degrees of
undernutrition and inflammatory
activity and leading to abnormal
body composition and diminished
function
Three types of function = Quality of Life
•Muscle function
•Strength
•Reservoir of substrate to support an
adequate metabolic response to
trauma/disease
•Immune function
•Allowing to generate an inflammatory (=
healing) response
•Cognitive function
•To allow thinking, remembering, feeling
well, managing life etc
Nutritional Assessment
=
Risk Assessment
Kudsk et al,
JPEN 2003
27: 1-9
P.o. day -2 y to -9
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol 7,1
Leuco’s/fl 23
Alb g/L 31
Kreat µM/L 153
BW kg 66-58 60
?
Why does Bodyweight (BW) increase from 58 to 60 kg?
Mrs. van der G., 62 y old at the emergency ward
Questions:
•Mrs. van der G. is dehydrated. How do you
rehydrate her?
•Mrs. van der G. is malnourished
•Does she need an operation and if so does
she need preoperative nutrition? Or is she
so ill that she needs an operation acutely?
After 6 hours of preparation (rehydration, nasal tube
suction, high rectal enema):
• No improvement of bowel function
• Immediate operation
• Volvulus of one of the first loops of the jejunum, necrotic.
• Generalized peritonitis.
• Resection of the loop (50 cm) and primary anastomosis.
Questions:
• Is this wise?
• Would you have done something differently?
• Which nutritional regimen do you prescribe and when should this be
started?
• Would you have created a gastrostomy or jejunostomy to feed?
Immediate postoperative course
• No improvement, patient remains ill
• Much fluid support is necessary to keep urine production up
• Fever
• Nasal stomach tube: approximately 1600 ml/24h comes out
• Tube feeding is impossible.
• After 5 days the midline incision opens due to a wound
abscess; dehiscence of the abdominal wall.
• Development of an acute respiratory insufficiency.
9 days after operation she is transferred to the Maastricht
University Medical Centre (MUMC), the Netherlands to the
ICU.
What are the priorities of treatment?
SOWATS guideline
•Treatment concept
•Sepsis control
•Optimization of nutritional state
•Wound care
•Anatomy of the fistula
•Timing of surgery
•Surgical strategy
Visschers, R. G., et al. (2008). "Treatment strategies in 135 consecutive patients with
enterocutaneous fistulas." World J Surg 32(3): 445-453.
•She barely escapes artificial ventilation.
•A CT scan is made of the abdomen.
SOWATS guideline: Sepsis control
Mrs. van der G., 62 y old, 9 days after operation
•CT scan abdomen: intra-abdominal abscess.
•Abcess drainage via a small surgical incision after
radiologic puncture drainage had failed
•A day later:
• Discharge of bile through the small wound.
• In a few days a high output fistula develops (over 1500
ml per day) draining like a loop jejunostomy.
• The fistula arose from lesions caused by the dissection of
inflamed intestine (peritonitis) or from the anastomosis
during the earlier operation.
•Questions:
•How do you nourish her?
•Which nutrients can still be adequately absorbed in
the 50 cm of intact jejunum that is still in
continuity with the oesophagus, stomach and
Medical Physiology
Boron, Boulpaep
Saunders
High output jejunal fistula
In the two following weeks (3 ½ weeks
after admittance) almost all organ
functions improve (Improvement of
respiratory and renal function, and
discontinuation of inotropic support)
Fistula output increases to 2000-2500
ml/24h.
P.o. day -2 y to -10
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol 7,1 5,6 6,7
Leuco’s/fl 23 18 11
Alb g/L 31 15 23
Kreat µM/L 153 120 56
BW kg 66-58 60 65 56
Why does albumin increase?
Why does the body weight decrease?
•In the two following weeks (3 ½ weeks after
admittance) almost all organ functions improve
(Improvement of respiratory and renal function,
and discontinuation of inotropic support) Fistula
output increase to 2000-2500 ml/24h. But ………..
Mrs vd G. gets jaundiced (yellow skin).
• Alk Phosphatase 4x elevated
•  GT 4x elevated
• Direct Bilirubin 230 µmol
• Transaminases slightly elevated
• Triglyceride levels 3-4 mmol
• Inflammatory parameters modest inflammation.
• Albumin > 23 g/l without Albumin infusion.
Rinsema et al
SGO 1988 167: 372-6
Rinsema et al, SGO 1988
Rinsema W, Gouma DJ, von Meyenfeldt MF, Soeters PB. Reinfusion of secretions from
high-output proximal stomas or fistulas. Surg Gynecol Obstet. 1988;167(5):372-6.
Activation of the Nuclear bile acid receptor
(Farnesoid receptor; FXR) with bile :
• Diminishes intestinal inflammation, liver cholestasis and
steatosis when activated by
• Re-establishing primary bile acid pool by
operation/reinfusion or UDCA, CA, norUDCA
• Synthetic FXR activators
• Improves intestinal integrity
• Decreases Triglyceride and Cholesterol content in the liver
and VLDL assemby
• FXR deletion/ malfunction increases fat content of the liver
Nutritional support:
• 1000 ml of enteral formula feeding per day together with a large part
of the proximal pancreatic and biliary secretions.
• PN is diminished to 1000 ml/d without lipid.
• 2x/week 500 ml 10% lipid emulsion
• 0,5-1.0 litres of balanced salt solution supplemented with Mg, Ca, Zn
=> electrolytes normalize.
After three weeks:
• Alk Phosphatase High range of normal
• Gamma- GT High range of normal
• Direct Bilirubin 20 µmol (high range of normal)
• Transaminases Normal
• Triglyceride levels 1-2 mmol (2x/week 500 ml 10% lipid
emulsion)
• Inflammatory parameters CRP 20 mg/L
• Albumin > 25 g/l without Albumin infusion.
P.o. day -2 y to -10
At Home
-1d
Elsewhere
9d
MUMC
25d
MUMC
50d
MUMC
Hb mmol 7,1 5,6 6,7 7,8
Leuco’s/fl 23 18 11 7,5
Alb g/L 31 15 23 32
Kreat µM/L 153 120 56 63
BW kg 66-58 60 65 56 56
Why does she not gain weight?
How does her body composition change?
•Physical, cognitive and biochemical improvement.
•Alb, Hb, rise.
•Intrahepatic cholestasis/jaundice disappear
completely.
•35 days after operation transfer from ICU to normal
ward.
•Physiotherapy was started in ICU and continued in
physiotherapy ward.
• 56 days after her first operation reoperation:
•Jejunal fistula is closed
•Abdominal wound is closed. The skin is left open.
•Mrs B. resumes oral intake a few days after the
operation and is discharged 70 days after her
admittance to the ICU.
SOWATS: Optimization of nutritional state
•± 70% of fistula patients are severely
malnourished
•Inadequate food intake and malabsorption
•Catabolism due to inflammation/infection
•Short bowel
•Malnutrition leads to:
•Bad healing of wounds
•Bad healing of anastomoses
•Lack of bile in the bowel leads to
inflammation in the bowel and in the liver
SOWATS: Optimization of nutritional state
•Total parenteral nutrition when fistula may
heal spontaneously; some enteral (500 ml)
•Always enteral if possible:
•when fistula will not heal spontaneously
•when fistula output does not damage the
wound
•add parenteral nutrition when not enough
enteral can be given or absorbed
•Physiotherapy
Development of enterocutaneous fistula
Spontaneous or surgical perforation => abcess
=> rupture/drainage abscess to skin or other
organ=> fistula
Formation Cause
Spontaneous
10-25%
Crohn’s disease
Cancer
Diverticulitis
Radiation enteritis
Surgical
75-90%
Iatrogenic lesion (sutures)
Anastomotic failure
Abdominal wall dehiscence
Mesh rupture
Drain puncture
Traumatic
<5%
Diagnostic intervention (puncture)
(Traffic) accident
Gun shot wound
Knife injury
Enterocutaneous fistulas
•Small bowel fistulas:
•Frequently high output
•Short bowel => malabsorption =>
metabolic disturbances
•=> metabolic disorders
•Malnutrition
•Dehydration
•Electrolyte disorders
•Cholestasis/ fatty liver
•Mucosal inflammation
Mortality in fistulas
•In the past:
•Sepsis
•Lack of nutritional support
•Fluid and electrolyte imbalance (especially
in the past)
•At present:
•Sepsis
Advances in treatment
•Parenteral/Enteral nutrition techniques
•Intensive care medicine
•Surgical technique
•Radiology (Ct and others) and
intervention
•Intestinal failure unit/ teams
•Management skills
Current treatment strategy
•There are no randomized controlled trials
(possible) but treatment is based on
cohort studies, case reports and expert
opinion from specialized referral centers
•Development of standardized treatment
strategies (protocol/guidelines)
SOWATS: Sepsis leading to organ disfunction
and malnutrition
•Most often cause of death in fistula patients
•Often due to inadequate drainage
•Treatment first priority
•Preferably CT-guided puncture of abscesses
•Prevent complete laparotomy if possible
because of many complications at this
moment
•Only antibiotics have little effect, should be
based on cultures but are ineffective in the
presence of major abscesses.
Diagnosis fistula in case of fluid
drainage of unknown origin
•Food substances (e.g. fiber)
•High concentrations of bilirubin/amylase
•Puncture abdominal fluid:
•Gram stain and culture
•Alb (low when intestinal content)
•Creat, amylase, bilirubin
•Cytology when malignancy possible
•Radiology
Signs of sepsis improvement
•Patients feel better
•No fever
•Disappearance of edema/ drying up
•Negative fluid balance
•Wrinkling of the skin
•Interest in surroundings
•Much stronger, gets out of bed
•Becomes impatient, wants to be operated
•Hb, Alb increase
•CRP, Sedimentation rate, Leucocytes decrease
Enteral Nutrition
•How much bowel is necessary to take up
enough nutrition by enteral route?
•> 200 cm small bowel without colon
•> 50-150 cm small bowel with colon
•When long segment (75-100 cm) distal small
bowel excluded:
•Re-infusion of (high) output from the
entero-cutaneous fistula
Parenteral nutrition
•Main goal:
•Maximize nutritional status
•Decrease fistula output by limiting
enteral nutrition
•Bridging to surgical closure
•Makes wound care easier
•Allows easier spontaneous closure
SOWATS: Wound care
•Low output < 500 ml, high output > 500 ml/day
•Intestinal fluid loss = loss of fluid and electrolytes
•Proteolytic activity of intestinal enzymes requires:
•In small wounds with low output fistula barrier and
keeping skin dry
•Large abdominal wall defects with high output fistulas
treatment with wound bags and sump suction drainage
•No vacuum devices on exposed bowel
•Proton pump inhibitors to diminish gastric secretion
•No significant effects of Somatostatin analogues
•Motility inhibitors (Imodium, Loperamide)
Wound care (of another patient)
• Daily inspection and care
• Stoma / wound care nurses
Day 0 Day 0 Day 7 Day 49
SOWATS: Anatomical evaluation
Spontaneous closure
Overall spontaneous
closure rate 20-30%
•Usually occurs
within 30 days after
development of the
fistula
•When spontaneous
closure does not
occur surgical
treatment is
generally needed
Negative predictors
for spontaneous
closure
• Major dehiscence of the
anastomosis
• Short fistula tract
• Distal obstruction
• Epithelialised fistula tract
• Sepsis or nearby abscess cavity
• High output ECF
• Chronic ECF
• Fistula in an open abdominal
wound
• Non-surgical cause
• Referrals
• Jejuno-ileal ECF
SOWATS: Timing of surgery
•Wait at least 6-12 weeks before performing
restorative surgery to allow the abdomen to
become accessible again
•Sepsis should be controlled
•Dry, loss of edema, wrinkling of the skin
•Biochemical parameters (albumin > > 25
g/L)
•Adequate nutritional status
•Clinical parameters (muscle, immune,
cognition)
SOWATS: Surgical closure
•Performed in 60-80% of patients
•Successful in 85-90% of cases in centers
•45-70% of the overall closure rate
•Resection of fistula tract and diseased bowel
•Reconnection of the intestine
•Sutures surrounded by healthy tissue, not
exposed to other suture lines or wound
closure
•Closure of the abdominal wall with fascia or
Vicryl mesh
Overview reviewed/ treated series
0
10
20
30
40
50
60
70
80
90
100
'46-'59 '60-'70 '70-'75 '77-'87 '90-'05
reviewed period
%patients
mortality overall closure rate (%)
Edmunds, Williams, Welch: Ann. Surg. 1960
Soeters, Fischer, Franklin: Arch. Chir. Neerl. 1977
Soeters, Ebeid, Fischer: Ann. Surg. 1979
Rinsema, Gouma, von Meyenfeldt, van der Linden, Soeters: Acta Chir. Scand. 1990
Visscher, Olde Damink, Winkens, Soeters, van Gemert: Ann. Surg. 2008
157 119 404 114 135
9 days after operation the following lab parameters are found:
• Hb 5.6 mmol/L
• ESR 36 mm/first hour
• Leucocytes 18/ fliter
• CRP 115 mg/l
• Kreat 120 mol/l
• Albumin 15 g/l
• BUN 9 mmol/l
• Electrolytes
• Na 128 mmol/l
• K 5.6 mmol/l
• Cl 115 mmol
• Liver enzymes
• AF and GTP Slightly elevated
• Transaminases normal
• Bilirubin 19 μmol/l
• Ca 1.7 mmol/l
• Mg 0.41 mmol/l
• Zn 7 mol/l
• Cu 39 mol/l
• Fe 8 mol/l
• Transferrin 2.80 mmol/l
• Triglycerides 2.3 mmol/l
Conclusion
•Patients with abdominal catastrophe/
enterocutaneous fistula suffer from multiple
complications
•Treatment is complex and requires
multidisciplinary expertise
•SOWATS approach is necessary
•Consider nutritional and metabolic complications
•Treat sepsis, institute nutrition and
physiotherapy: are crucial elements of treatment
•Timing and art of surgery are also important
•One captain and one deputy captain on the ship

More Related Content

What's hot

Management of enterocutaneous fistula
Management of enterocutaneous fistulaManagement of enterocutaneous fistula
Management of enterocutaneous fistula
bbthapa
 
Interstitial cystitis
Interstitial cystitisInterstitial cystitis
Interstitial cystitis
AKSHATA RAO
 
Short Bowel Syndrome
Short Bowel SyndromeShort Bowel Syndrome
Short Bowel Syndrome
Oladele Situ
 
Discuss the Pathology and Management of Short Bowel Syndrome presentation
Discuss the Pathology and Management of Short Bowel Syndrome presentationDiscuss the Pathology and Management of Short Bowel Syndrome presentation
Discuss the Pathology and Management of Short Bowel Syndrome presentation
Oladele Situ
 
Infantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosisInfantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosis
AbdullahIhsaas
 
Surgery in chronic pancreatitis
Surgery in chronic pancreatitis Surgery in chronic pancreatitis
Surgery in chronic pancreatitis
Sumer Yadav
 
Management of pud
Management of pud Management of pud
Management of pud
biruk ertiban
 
Kalafsky Major
Kalafsky MajorKalafsky Major
Kalafsky Major
clkalafsky
 
Enterocutaneous fistula
Enterocutaneous fistulaEnterocutaneous fistula
Enterocutaneous fistula
FidelSimba
 
Case Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal UlcerCase Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal Ulcer
ksaigowtham
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
Dr.S.K.Jain Surgical Team
 
Management of Chronic Pancreatitis
Management of Chronic PancreatitisManagement of Chronic Pancreatitis
Management of Chronic Pancreatitis
Dr. Shouptik Basu
 
Peptic Ulcer Saint James School of Medicine
Peptic Ulcer Saint James School of Medicine Peptic Ulcer Saint James School of Medicine
Peptic Ulcer Saint James School of Medicine
bimmerque
 
Intestinal transplant
Intestinal transplantIntestinal transplant
Intestinal transplant
Mahesh Raj
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
Subramani Parasuraman
 
Ogilvie syndrom
Ogilvie syndromOgilvie syndrom
Ogilvie syndrom
jdacostap
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
Bimel Kottarathil
 
Entero cutaneous fistulae
Entero cutaneous fistulaeEntero cutaneous fistulae
Entero cutaneous fistulae
Wasula Rathnaweera
 
Chronic pancreatitis and its surgical management
Chronic pancreatitis and its surgical managementChronic pancreatitis and its surgical management
Chronic pancreatitis and its surgical management
rks sivasankar
 
Maneesh sharma
Maneesh sharmaManeesh sharma
Maneesh sharma
Manish Sharma
 

What's hot (20)

Management of enterocutaneous fistula
Management of enterocutaneous fistulaManagement of enterocutaneous fistula
Management of enterocutaneous fistula
 
Interstitial cystitis
Interstitial cystitisInterstitial cystitis
Interstitial cystitis
 
Short Bowel Syndrome
Short Bowel SyndromeShort Bowel Syndrome
Short Bowel Syndrome
 
Discuss the Pathology and Management of Short Bowel Syndrome presentation
Discuss the Pathology and Management of Short Bowel Syndrome presentationDiscuss the Pathology and Management of Short Bowel Syndrome presentation
Discuss the Pathology and Management of Short Bowel Syndrome presentation
 
Infantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosisInfantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosis
 
Surgery in chronic pancreatitis
Surgery in chronic pancreatitis Surgery in chronic pancreatitis
Surgery in chronic pancreatitis
 
Management of pud
Management of pud Management of pud
Management of pud
 
Kalafsky Major
Kalafsky MajorKalafsky Major
Kalafsky Major
 
Enterocutaneous fistula
Enterocutaneous fistulaEnterocutaneous fistula
Enterocutaneous fistula
 
Case Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal UlcerCase Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal Ulcer
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
Management of Chronic Pancreatitis
Management of Chronic PancreatitisManagement of Chronic Pancreatitis
Management of Chronic Pancreatitis
 
Peptic Ulcer Saint James School of Medicine
Peptic Ulcer Saint James School of Medicine Peptic Ulcer Saint James School of Medicine
Peptic Ulcer Saint James School of Medicine
 
Intestinal transplant
Intestinal transplantIntestinal transplant
Intestinal transplant
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
Ogilvie syndrom
Ogilvie syndromOgilvie syndrom
Ogilvie syndrom
 
Peptic ulcer disease
Peptic ulcer diseasePeptic ulcer disease
Peptic ulcer disease
 
Entero cutaneous fistulae
Entero cutaneous fistulaeEntero cutaneous fistulae
Entero cutaneous fistulae
 
Chronic pancreatitis and its surgical management
Chronic pancreatitis and its surgical managementChronic pancreatitis and its surgical management
Chronic pancreatitis and its surgical management
 
Maneesh sharma
Maneesh sharmaManeesh sharma
Maneesh sharma
 

Similar to Питер Сутерс "Проблемные вопросы лечения свищей"

ENTERAL AND PARENTERAL NUTRITION.pptx
ENTERAL AND PARENTERAL NUTRITION.pptxENTERAL AND PARENTERAL NUTRITION.pptx
ENTERAL AND PARENTERAL NUTRITION.pptx
KavitaKumari223111
 
Nutrition icu
Nutrition icuNutrition icu
Nutrition icu
Doha Rasheedy
 
Enterocutanoeus fistula
Enterocutanoeus fistulaEnterocutanoeus fistula
Enterocutanoeus fistula
Preethiya Seenivasan
 
PSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYSTPSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYST
Dr. Shouptik Basu
 
The gallbladder, cholesysitis and acute pancreatitis
The gallbladder, cholesysitis and acute pancreatitisThe gallbladder, cholesysitis and acute pancreatitis
The gallbladder, cholesysitis and acute pancreatitis
Lindsey Callihan, MS, RD, CD
 
Phenomena of normal prepurium and care of postpartum
Phenomena of normal prepurium and care of postpartum Phenomena of normal prepurium and care of postpartum
Phenomena of normal prepurium and care of postpartum
ITM UNIVERSITY,GWALIOR
 
Mebrofenin scintigraphy in bile disorders
Mebrofenin scintigraphy in bile disordersMebrofenin scintigraphy in bile disorders
Mebrofenin scintigraphy in bile disorders
Ravishwar Narayan
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
JabeMohammed
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
Dhaval Mangukiya
 
Ogilvie syndrome and a Review of the Pharmacologic Treatment of Constipation
Ogilvie syndrome and a Review of the Pharmacologic Treatment of ConstipationOgilvie syndrome and a Review of the Pharmacologic Treatment of Constipation
Ogilvie syndrome and a Review of the Pharmacologic Treatment of Constipation
mfabzak
 
Constipation
ConstipationConstipation
Constipation
Shaimaa Elkholy
 
Concept of Elimination...docx
Concept of Elimination...docxConcept of Elimination...docx
Concept of Elimination...docx
CITY NURSING SCHOOL
 
Management of Gastro-esophageal reflux disease
Management of Gastro-esophageal reflux diseaseManagement of Gastro-esophageal reflux disease
Management of Gastro-esophageal reflux disease
Vamsi Alluri
 
Colostomy power point is very important for students
Colostomy power point is very important for studentsColostomy power point is very important for students
Colostomy power point is very important for students
tembotisa26
 
HIRSCHSPRUNG DISEASE of neonate wrr.pptx
HIRSCHSPRUNG DISEASE of neonate wrr.pptxHIRSCHSPRUNG DISEASE of neonate wrr.pptx
HIRSCHSPRUNG DISEASE of neonate wrr.pptx
ShambelNegese
 
Entero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. OnkarEntero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. Onkar
guesta40423
 
Pemicu 5 blok GIT.pptx
Pemicu 5 blok GIT.pptxPemicu 5 blok GIT.pptx
Pemicu 5 blok GIT.pptx
FeleciaChristy
 
Intestinal Fistula
Intestinal FistulaIntestinal Fistula
Intestinal Fistula
KIST Surgery
 
Managament of anastomotic leak - case capsule- Dr Keyur Bhatt
Managament of anastomotic leak  - case capsule- Dr Keyur BhattManagament of anastomotic leak  - case capsule- Dr Keyur Bhatt
Managament of anastomotic leak - case capsule- Dr Keyur Bhatt
DrKeyurBhattMSMRCSEd
 
Enterocutaneous fistula fecal fistula neo.pptx
Enterocutaneous fistula fecal fistula neo.pptxEnterocutaneous fistula fecal fistula neo.pptx
Enterocutaneous fistula fecal fistula neo.pptx
Nawin Kumar
 

Similar to Питер Сутерс "Проблемные вопросы лечения свищей" (20)

ENTERAL AND PARENTERAL NUTRITION.pptx
ENTERAL AND PARENTERAL NUTRITION.pptxENTERAL AND PARENTERAL NUTRITION.pptx
ENTERAL AND PARENTERAL NUTRITION.pptx
 
Nutrition icu
Nutrition icuNutrition icu
Nutrition icu
 
Enterocutanoeus fistula
Enterocutanoeus fistulaEnterocutanoeus fistula
Enterocutanoeus fistula
 
PSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYSTPSEUDOPANCREATIC CYST
PSEUDOPANCREATIC CYST
 
The gallbladder, cholesysitis and acute pancreatitis
The gallbladder, cholesysitis and acute pancreatitisThe gallbladder, cholesysitis and acute pancreatitis
The gallbladder, cholesysitis and acute pancreatitis
 
Phenomena of normal prepurium and care of postpartum
Phenomena of normal prepurium and care of postpartum Phenomena of normal prepurium and care of postpartum
Phenomena of normal prepurium and care of postpartum
 
Mebrofenin scintigraphy in bile disorders
Mebrofenin scintigraphy in bile disordersMebrofenin scintigraphy in bile disorders
Mebrofenin scintigraphy in bile disorders
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Ogilvie syndrome and a Review of the Pharmacologic Treatment of Constipation
Ogilvie syndrome and a Review of the Pharmacologic Treatment of ConstipationOgilvie syndrome and a Review of the Pharmacologic Treatment of Constipation
Ogilvie syndrome and a Review of the Pharmacologic Treatment of Constipation
 
Constipation
ConstipationConstipation
Constipation
 
Concept of Elimination...docx
Concept of Elimination...docxConcept of Elimination...docx
Concept of Elimination...docx
 
Management of Gastro-esophageal reflux disease
Management of Gastro-esophageal reflux diseaseManagement of Gastro-esophageal reflux disease
Management of Gastro-esophageal reflux disease
 
Colostomy power point is very important for students
Colostomy power point is very important for studentsColostomy power point is very important for students
Colostomy power point is very important for students
 
HIRSCHSPRUNG DISEASE of neonate wrr.pptx
HIRSCHSPRUNG DISEASE of neonate wrr.pptxHIRSCHSPRUNG DISEASE of neonate wrr.pptx
HIRSCHSPRUNG DISEASE of neonate wrr.pptx
 
Entero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. OnkarEntero Cutaneous Fistula by Dr. Onkar
Entero Cutaneous Fistula by Dr. Onkar
 
Pemicu 5 blok GIT.pptx
Pemicu 5 blok GIT.pptxPemicu 5 blok GIT.pptx
Pemicu 5 blok GIT.pptx
 
Intestinal Fistula
Intestinal FistulaIntestinal Fistula
Intestinal Fistula
 
Managament of anastomotic leak - case capsule- Dr Keyur Bhatt
Managament of anastomotic leak  - case capsule- Dr Keyur BhattManagament of anastomotic leak  - case capsule- Dr Keyur Bhatt
Managament of anastomotic leak - case capsule- Dr Keyur Bhatt
 
Enterocutaneous fistula fecal fistula neo.pptx
Enterocutaneous fistula fecal fistula neo.pptxEnterocutaneous fistula fecal fistula neo.pptx
Enterocutaneous fistula fecal fistula neo.pptx
 

More from rnw-aspen

"Нутриционная поддержка и реабилитация: врач-ребенок-мама" Коровина И.В.(Мос...
"Нутриционная поддержка и реабилитация: врач-ребенок-мама"  Коровина И.В.(Мос..."Нутриционная поддержка и реабилитация: врач-ребенок-мама"  Коровина И.В.(Мос...
"Нутриционная поддержка и реабилитация: врач-ребенок-мама" Коровина И.В.(Мос...
rnw-aspen
 
"Нутриционная поддержка детей с органическими поражениями головного мозга" З...
"Нутриционная поддержка детей с органическими поражениями головного мозга"  З..."Нутриционная поддержка детей с органическими поражениями головного мозга"  З...
"Нутриционная поддержка детей с органическими поражениями головного мозга" З...
rnw-aspen
 
"Опыт организации группы нутритивной терапии в федеральном научно-клиническом...
"Опыт организации группы нутритивной терапии в федеральном научно-клиническом..."Опыт организации группы нутритивной терапии в федеральном научно-клиническом...
"Опыт организации группы нутритивной терапии в федеральном научно-клиническом...
rnw-aspen
 
"Нарушения нутритивного статуса и возможности его коррекции у пациентов после...
"Нарушения нутритивного статуса и возможности его коррекции у пациентов после..."Нарушения нутритивного статуса и возможности его коррекции у пациентов после...
"Нарушения нутритивного статуса и возможности его коррекции у пациентов после...
rnw-aspen
 
"Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст...
"Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст..."Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст...
"Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст...
rnw-aspen
 
"Распространенность и выраженность недостаточности питания среди пациентов ФН...
"Распространенность и выраженность недостаточности питания среди пациентов ФН..."Распространенность и выраженность недостаточности питания среди пациентов ФН...
"Распространенность и выраженность недостаточности питания среди пациентов ФН...
rnw-aspen
 
"Первый опыт организации домашнего парентерального питания детей в Санкт-Пете...
"Первый опыт организации домашнего парентерального питания детей в Санкт-Пете..."Первый опыт организации домашнего парентерального питания детей в Санкт-Пете...
"Первый опыт организации домашнего парентерального питания детей в Санкт-Пете...
rnw-aspen
 
"Хронический интестинальный псевдообструктивный синдром: современные тренды д...
"Хронический интестинальный псевдообструктивный синдром: современные тренды д..."Хронический интестинальный псевдообструктивный синдром: современные тренды д...
"Хронический интестинальный псевдообструктивный синдром: современные тренды д...
rnw-aspen
 
"Альбумин в интенсивной терапии критических состояний у детей" Пшениснов К.В...
"Альбумин в интенсивной терапии критических состояний у детей"  Пшениснов К.В..."Альбумин в интенсивной терапии критических состояний у детей"  Пшениснов К.В...
"Альбумин в интенсивной терапии критических состояний у детей" Пшениснов К.В...
rnw-aspen
 
"Синтетические коллоиды в интенсивной терапии шока у детей. За и против?" Ал...
"Синтетические коллоиды в интенсивной терапии шока у детей. За и против?"  Ал..."Синтетические коллоиды в интенсивной терапии шока у детей. За и против?"  Ал...
"Синтетические коллоиды в интенсивной терапии шока у детей. За и против?" Ал...
rnw-aspen
 
Различные варианты сосудистого доступа для пациентов, получающих прентерально...
Различные варианты сосудистого доступа для пациентов, получающих прентерально...Различные варианты сосудистого доступа для пациентов, получающих прентерально...
Различные варианты сосудистого доступа для пациентов, получающих прентерально...
rnw-aspen
 
"Проблемные вопросы полного парентерального питания больных в клинической пра...
"Проблемные вопросы полного парентерального питания больных в клинической пра..."Проблемные вопросы полного парентерального питания больных в клинической пра...
"Проблемные вопросы полного парентерального питания больных в клинической пра...
rnw-aspen
 
"Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны...
"Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны..."Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны...
"Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны...
rnw-aspen
 
"Синдром короткой кишки - проблемы лечения и возможные перспективы" Луфт В....
"Синдром короткой кишки - проблемы лечения и возможные перспективы"   Луфт В...."Синдром короткой кишки - проблемы лечения и возможные перспективы"   Луфт В....
"Синдром короткой кишки - проблемы лечения и возможные перспективы" Луфт В....
rnw-aspen
 
"Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты" Ярош...
"Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты"  Ярош..."Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты"  Ярош...
"Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты" Ярош...
rnw-aspen
 
"Клиническая демонстрация больного с осложненным течением острого деструктивн...
"Клиническая демонстрация больного с осложненным течением острого деструктивн..."Клиническая демонстрация больного с осложненным течением острого деструктивн...
"Клиническая демонстрация больного с осложненным течением острого деструктивн...
rnw-aspen
 
"Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко...
"Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко..."Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко...
"Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко...
rnw-aspen
 
"Сепсис: новые взгляды на старую проблему" Кулабухов В.В., Руднов В.А. (Москва)
"Сепсис: новые взгляды на старую проблему"  Кулабухов В.В., Руднов В.А. (Москва)"Сепсис: новые взгляды на старую проблему"  Кулабухов В.В., Руднов В.А. (Москва)
"Сепсис: новые взгляды на старую проблему" Кулабухов В.В., Руднов В.А. (Москва)
rnw-aspen
 
"Инфузионная и нутритивная терапия больных с острым панкреатитом" Соботка Л....
"Инфузионная и нутритивная терапия больных с острым панкреатитом"  Соботка Л...."Инфузионная и нутритивная терапия больных с острым панкреатитом"  Соботка Л....
"Инфузионная и нутритивная терапия больных с острым панкреатитом" Соботка Л....
rnw-aspen
 
"Проблемные вопросы инфузионной терапии острого панкреатита" Афончиков В.С...
"Проблемные вопросы инфузионной терапии острого панкреатита"    Афончиков В.С..."Проблемные вопросы инфузионной терапии острого панкреатита"    Афончиков В.С...
"Проблемные вопросы инфузионной терапии острого панкреатита" Афончиков В.С...
rnw-aspen
 

More from rnw-aspen (20)

"Нутриционная поддержка и реабилитация: врач-ребенок-мама" Коровина И.В.(Мос...
"Нутриционная поддержка и реабилитация: врач-ребенок-мама"  Коровина И.В.(Мос..."Нутриционная поддержка и реабилитация: врач-ребенок-мама"  Коровина И.В.(Мос...
"Нутриционная поддержка и реабилитация: врач-ребенок-мама" Коровина И.В.(Мос...
 
"Нутриционная поддержка детей с органическими поражениями головного мозга" З...
"Нутриционная поддержка детей с органическими поражениями головного мозга"  З..."Нутриционная поддержка детей с органическими поражениями головного мозга"  З...
"Нутриционная поддержка детей с органическими поражениями головного мозга" З...
 
"Опыт организации группы нутритивной терапии в федеральном научно-клиническом...
"Опыт организации группы нутритивной терапии в федеральном научно-клиническом..."Опыт организации группы нутритивной терапии в федеральном научно-клиническом...
"Опыт организации группы нутритивной терапии в федеральном научно-клиническом...
 
"Нарушения нутритивного статуса и возможности его коррекции у пациентов после...
"Нарушения нутритивного статуса и возможности его коррекции у пациентов после..."Нарушения нутритивного статуса и возможности его коррекции у пациентов после...
"Нарушения нутритивного статуса и возможности его коррекции у пациентов после...
 
"Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст...
"Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст..."Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст...
"Нутритивный статус у детей, подвергающихся трансплантации гемопоэтических ст...
 
"Распространенность и выраженность недостаточности питания среди пациентов ФН...
"Распространенность и выраженность недостаточности питания среди пациентов ФН..."Распространенность и выраженность недостаточности питания среди пациентов ФН...
"Распространенность и выраженность недостаточности питания среди пациентов ФН...
 
"Первый опыт организации домашнего парентерального питания детей в Санкт-Пете...
"Первый опыт организации домашнего парентерального питания детей в Санкт-Пете..."Первый опыт организации домашнего парентерального питания детей в Санкт-Пете...
"Первый опыт организации домашнего парентерального питания детей в Санкт-Пете...
 
"Хронический интестинальный псевдообструктивный синдром: современные тренды д...
"Хронический интестинальный псевдообструктивный синдром: современные тренды д..."Хронический интестинальный псевдообструктивный синдром: современные тренды д...
"Хронический интестинальный псевдообструктивный синдром: современные тренды д...
 
"Альбумин в интенсивной терапии критических состояний у детей" Пшениснов К.В...
"Альбумин в интенсивной терапии критических состояний у детей"  Пшениснов К.В..."Альбумин в интенсивной терапии критических состояний у детей"  Пшениснов К.В...
"Альбумин в интенсивной терапии критических состояний у детей" Пшениснов К.В...
 
"Синтетические коллоиды в интенсивной терапии шока у детей. За и против?" Ал...
"Синтетические коллоиды в интенсивной терапии шока у детей. За и против?"  Ал..."Синтетические коллоиды в интенсивной терапии шока у детей. За и против?"  Ал...
"Синтетические коллоиды в интенсивной терапии шока у детей. За и против?" Ал...
 
Различные варианты сосудистого доступа для пациентов, получающих прентерально...
Различные варианты сосудистого доступа для пациентов, получающих прентерально...Различные варианты сосудистого доступа для пациентов, получающих прентерально...
Различные варианты сосудистого доступа для пациентов, получающих прентерально...
 
"Проблемные вопросы полного парентерального питания больных в клинической пра...
"Проблемные вопросы полного парентерального питания больных в клинической пра..."Проблемные вопросы полного парентерального питания больных в клинической пра...
"Проблемные вопросы полного парентерального питания больных в клинической пра...
 
"Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны...
"Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны..."Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны...
"Синдром короткой кишки у детей: нутритивная поддержка до и после аутологичны...
 
"Синдром короткой кишки - проблемы лечения и возможные перспективы" Луфт В....
"Синдром короткой кишки - проблемы лечения и возможные перспективы"   Луфт В...."Синдром короткой кишки - проблемы лечения и возможные перспективы"   Луфт В....
"Синдром короткой кишки - проблемы лечения и возможные перспективы" Луфт В....
 
"Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты" Ярош...
"Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты"  Ярош..."Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты"  Ярош...
"Нутритивно-метаболическая терапия при ОРДС: обсуждаем спорные моменты" Ярош...
 
"Клиническая демонстрация больного с осложненным течением острого деструктивн...
"Клиническая демонстрация больного с осложненным течением острого деструктивн..."Клиническая демонстрация больного с осложненным течением острого деструктивн...
"Клиническая демонстрация больного с осложненным течением острого деструктивн...
 
"Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко...
"Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко..."Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко...
"Метаболическая дисфункция при сепсисе: клинические проявления и подходы к ко...
 
"Сепсис: новые взгляды на старую проблему" Кулабухов В.В., Руднов В.А. (Москва)
"Сепсис: новые взгляды на старую проблему"  Кулабухов В.В., Руднов В.А. (Москва)"Сепсис: новые взгляды на старую проблему"  Кулабухов В.В., Руднов В.А. (Москва)
"Сепсис: новые взгляды на старую проблему" Кулабухов В.В., Руднов В.А. (Москва)
 
"Инфузионная и нутритивная терапия больных с острым панкреатитом" Соботка Л....
"Инфузионная и нутритивная терапия больных с острым панкреатитом"  Соботка Л...."Инфузионная и нутритивная терапия больных с острым панкреатитом"  Соботка Л....
"Инфузионная и нутритивная терапия больных с острым панкреатитом" Соботка Л....
 
"Проблемные вопросы инфузионной терапии острого панкреатита" Афончиков В.С...
"Проблемные вопросы инфузионной терапии острого панкреатита"    Афончиков В.С..."Проблемные вопросы инфузионной терапии острого панкреатита"    Афончиков В.С...
"Проблемные вопросы инфузионной терапии острого панкреатита" Афончиков В.С...
 

Recently uploaded

PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
Golden Helix
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
KENT'S REPERTORY by dr niranjan mohanty.pptx
KENT'S REPERTORY by dr niranjan mohanty.pptxKENT'S REPERTORY by dr niranjan mohanty.pptx
KENT'S REPERTORY by dr niranjan mohanty.pptx
SravsPandu1
 
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing studentsHelminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
RAJU B N
 
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
shruti jagirdar
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Planet Ayurveda
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
Dr Nitin Tyagi
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
Bhavyakelawadiya
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
Donc Test
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
MuskanShingari
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
TigistuMelak
 
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
MuskanShingari
 
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
ayushrajshrivastava7
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
Healthmedsrx.com
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
MwambaChikonde1
 

Recently uploaded (20)

PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
KENT'S REPERTORY by dr niranjan mohanty.pptx
KENT'S REPERTORY by dr niranjan mohanty.pptxKENT'S REPERTORY by dr niranjan mohanty.pptx
KENT'S REPERTORY by dr niranjan mohanty.pptx
 
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing studentsHelminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
 
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
 
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
 
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?What is Obesity? How to overcome Obesity?
What is Obesity? How to overcome Obesity?
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
 

Питер Сутерс "Проблемные вопросы лечения свищей"

  • 1. Do’s and Don’t’s in the management of intestinal fistulae St. Petersburg, Russia Peter B. Soeters the Netherlands
  • 2. Enterocutaneous fistula • Abnormal communication between the intestinal tract and the skin or a hollow organ
  • 3. • Mrs. Van der G., 62 years old, 1.68 m, 58 kg • no serious comorbidity, admitted to the emergency ward elsewhere • abdominal pain for 3 days, vomiting and no passage of stools since three days, no fever. • Medical history • Hysterectomy (removal of the uterus) 20 years earlier because of uncontrollable meno-, metrorhagies (bleeding). • Since years recurrent crampy pain and slight bowel distention with audible bowel sounds. This has been become worse and at times she has been anorectic. • Physical examination • Slight distension of the abdomen, no bowel sounds • Tenderness and rebound tenderness in the abdomen but especially in the left upper quadrant . • Clinically dehydrated. • Plain X-ray films of the abdomen in standing position:
  • 4. X- abdomen confirms the diagnosis small bowel obstruction
  • 5. P.o. day -2 y to -9 At Home -1d Elsewhere 9d MUMC 25d MUMC 50d MUMC Hb mmol N ± 7.3 – 8 7,1 Leuco’s/fl 23 Alb g/L N ± 40 31 Kreat µM/L N ± 80 153 BW kg 66-58 60 • Is the Hb normal? • Is she malnourished?
  • 6. What is Malnutrition? A nutritional state resulting from a combination of varying degrees of undernutrition and inflammatory activity and leading to abnormal body composition and diminished function
  • 7. Three types of function = Quality of Life •Muscle function •Strength •Reservoir of substrate to support an adequate metabolic response to trauma/disease •Immune function •Allowing to generate an inflammatory (= healing) response •Cognitive function •To allow thinking, remembering, feeling well, managing life etc
  • 9. Kudsk et al, JPEN 2003 27: 1-9
  • 10. P.o. day -2 y to -9 At Home -1d Elsewhere 9d MUMC 25d MUMC 50d MUMC Hb mmol 7,1 Leuco’s/fl 23 Alb g/L 31 Kreat µM/L 153 BW kg 66-58 60 ? Why does Bodyweight (BW) increase from 58 to 60 kg?
  • 11. Mrs. van der G., 62 y old at the emergency ward Questions: •Mrs. van der G. is dehydrated. How do you rehydrate her? •Mrs. van der G. is malnourished •Does she need an operation and if so does she need preoperative nutrition? Or is she so ill that she needs an operation acutely?
  • 12. After 6 hours of preparation (rehydration, nasal tube suction, high rectal enema): • No improvement of bowel function • Immediate operation • Volvulus of one of the first loops of the jejunum, necrotic. • Generalized peritonitis. • Resection of the loop (50 cm) and primary anastomosis. Questions: • Is this wise? • Would you have done something differently? • Which nutritional regimen do you prescribe and when should this be started? • Would you have created a gastrostomy or jejunostomy to feed?
  • 13. Immediate postoperative course • No improvement, patient remains ill • Much fluid support is necessary to keep urine production up • Fever • Nasal stomach tube: approximately 1600 ml/24h comes out • Tube feeding is impossible. • After 5 days the midline incision opens due to a wound abscess; dehiscence of the abdominal wall. • Development of an acute respiratory insufficiency. 9 days after operation she is transferred to the Maastricht University Medical Centre (MUMC), the Netherlands to the ICU.
  • 14. What are the priorities of treatment? SOWATS guideline •Treatment concept •Sepsis control •Optimization of nutritional state •Wound care •Anatomy of the fistula •Timing of surgery •Surgical strategy Visschers, R. G., et al. (2008). "Treatment strategies in 135 consecutive patients with enterocutaneous fistulas." World J Surg 32(3): 445-453.
  • 15. •She barely escapes artificial ventilation. •A CT scan is made of the abdomen. SOWATS guideline: Sepsis control
  • 16.
  • 17. Mrs. van der G., 62 y old, 9 days after operation •CT scan abdomen: intra-abdominal abscess. •Abcess drainage via a small surgical incision after radiologic puncture drainage had failed •A day later: • Discharge of bile through the small wound. • In a few days a high output fistula develops (over 1500 ml per day) draining like a loop jejunostomy. • The fistula arose from lesions caused by the dissection of inflamed intestine (peritonitis) or from the anastomosis during the earlier operation. •Questions: •How do you nourish her? •Which nutrients can still be adequately absorbed in the 50 cm of intact jejunum that is still in continuity with the oesophagus, stomach and
  • 19. In the two following weeks (3 ½ weeks after admittance) almost all organ functions improve (Improvement of respiratory and renal function, and discontinuation of inotropic support) Fistula output increases to 2000-2500 ml/24h.
  • 20. P.o. day -2 y to -10 At Home -1d Elsewhere 9d MUMC 25d MUMC 50d MUMC Hb mmol 7,1 5,6 6,7 Leuco’s/fl 23 18 11 Alb g/L 31 15 23 Kreat µM/L 153 120 56 BW kg 66-58 60 65 56 Why does albumin increase? Why does the body weight decrease?
  • 21. •In the two following weeks (3 ½ weeks after admittance) almost all organ functions improve (Improvement of respiratory and renal function, and discontinuation of inotropic support) Fistula output increase to 2000-2500 ml/24h. But ……….. Mrs vd G. gets jaundiced (yellow skin). • Alk Phosphatase 4x elevated •  GT 4x elevated • Direct Bilirubin 230 µmol • Transaminases slightly elevated • Triglyceride levels 3-4 mmol • Inflammatory parameters modest inflammation. • Albumin > 23 g/l without Albumin infusion.
  • 22.
  • 23. Rinsema et al SGO 1988 167: 372-6
  • 24. Rinsema et al, SGO 1988 Rinsema W, Gouma DJ, von Meyenfeldt MF, Soeters PB. Reinfusion of secretions from high-output proximal stomas or fistulas. Surg Gynecol Obstet. 1988;167(5):372-6.
  • 25. Activation of the Nuclear bile acid receptor (Farnesoid receptor; FXR) with bile : • Diminishes intestinal inflammation, liver cholestasis and steatosis when activated by • Re-establishing primary bile acid pool by operation/reinfusion or UDCA, CA, norUDCA • Synthetic FXR activators • Improves intestinal integrity • Decreases Triglyceride and Cholesterol content in the liver and VLDL assemby • FXR deletion/ malfunction increases fat content of the liver
  • 26. Nutritional support: • 1000 ml of enteral formula feeding per day together with a large part of the proximal pancreatic and biliary secretions. • PN is diminished to 1000 ml/d without lipid. • 2x/week 500 ml 10% lipid emulsion • 0,5-1.0 litres of balanced salt solution supplemented with Mg, Ca, Zn => electrolytes normalize. After three weeks: • Alk Phosphatase High range of normal • Gamma- GT High range of normal • Direct Bilirubin 20 µmol (high range of normal) • Transaminases Normal • Triglyceride levels 1-2 mmol (2x/week 500 ml 10% lipid emulsion) • Inflammatory parameters CRP 20 mg/L • Albumin > 25 g/l without Albumin infusion.
  • 27. P.o. day -2 y to -10 At Home -1d Elsewhere 9d MUMC 25d MUMC 50d MUMC Hb mmol 7,1 5,6 6,7 7,8 Leuco’s/fl 23 18 11 7,5 Alb g/L 31 15 23 32 Kreat µM/L 153 120 56 63 BW kg 66-58 60 65 56 56 Why does she not gain weight? How does her body composition change?
  • 28. •Physical, cognitive and biochemical improvement. •Alb, Hb, rise. •Intrahepatic cholestasis/jaundice disappear completely. •35 days after operation transfer from ICU to normal ward. •Physiotherapy was started in ICU and continued in physiotherapy ward. • 56 days after her first operation reoperation: •Jejunal fistula is closed •Abdominal wound is closed. The skin is left open. •Mrs B. resumes oral intake a few days after the operation and is discharged 70 days after her admittance to the ICU.
  • 29. SOWATS: Optimization of nutritional state •± 70% of fistula patients are severely malnourished •Inadequate food intake and malabsorption •Catabolism due to inflammation/infection •Short bowel •Malnutrition leads to: •Bad healing of wounds •Bad healing of anastomoses •Lack of bile in the bowel leads to inflammation in the bowel and in the liver
  • 30. SOWATS: Optimization of nutritional state •Total parenteral nutrition when fistula may heal spontaneously; some enteral (500 ml) •Always enteral if possible: •when fistula will not heal spontaneously •when fistula output does not damage the wound •add parenteral nutrition when not enough enteral can be given or absorbed •Physiotherapy
  • 31. Development of enterocutaneous fistula Spontaneous or surgical perforation => abcess => rupture/drainage abscess to skin or other organ=> fistula Formation Cause Spontaneous 10-25% Crohn’s disease Cancer Diverticulitis Radiation enteritis Surgical 75-90% Iatrogenic lesion (sutures) Anastomotic failure Abdominal wall dehiscence Mesh rupture Drain puncture Traumatic <5% Diagnostic intervention (puncture) (Traffic) accident Gun shot wound Knife injury
  • 32. Enterocutaneous fistulas •Small bowel fistulas: •Frequently high output •Short bowel => malabsorption => metabolic disturbances •=> metabolic disorders •Malnutrition •Dehydration •Electrolyte disorders •Cholestasis/ fatty liver •Mucosal inflammation
  • 33. Mortality in fistulas •In the past: •Sepsis •Lack of nutritional support •Fluid and electrolyte imbalance (especially in the past) •At present: •Sepsis
  • 34. Advances in treatment •Parenteral/Enteral nutrition techniques •Intensive care medicine •Surgical technique •Radiology (Ct and others) and intervention •Intestinal failure unit/ teams •Management skills
  • 35. Current treatment strategy •There are no randomized controlled trials (possible) but treatment is based on cohort studies, case reports and expert opinion from specialized referral centers •Development of standardized treatment strategies (protocol/guidelines)
  • 36. SOWATS: Sepsis leading to organ disfunction and malnutrition •Most often cause of death in fistula patients •Often due to inadequate drainage •Treatment first priority •Preferably CT-guided puncture of abscesses •Prevent complete laparotomy if possible because of many complications at this moment •Only antibiotics have little effect, should be based on cultures but are ineffective in the presence of major abscesses.
  • 37. Diagnosis fistula in case of fluid drainage of unknown origin •Food substances (e.g. fiber) •High concentrations of bilirubin/amylase •Puncture abdominal fluid: •Gram stain and culture •Alb (low when intestinal content) •Creat, amylase, bilirubin •Cytology when malignancy possible •Radiology
  • 38. Signs of sepsis improvement •Patients feel better •No fever •Disappearance of edema/ drying up •Negative fluid balance •Wrinkling of the skin •Interest in surroundings •Much stronger, gets out of bed •Becomes impatient, wants to be operated •Hb, Alb increase •CRP, Sedimentation rate, Leucocytes decrease
  • 39. Enteral Nutrition •How much bowel is necessary to take up enough nutrition by enteral route? •> 200 cm small bowel without colon •> 50-150 cm small bowel with colon •When long segment (75-100 cm) distal small bowel excluded: •Re-infusion of (high) output from the entero-cutaneous fistula
  • 40. Parenteral nutrition •Main goal: •Maximize nutritional status •Decrease fistula output by limiting enteral nutrition •Bridging to surgical closure •Makes wound care easier •Allows easier spontaneous closure
  • 41. SOWATS: Wound care •Low output < 500 ml, high output > 500 ml/day •Intestinal fluid loss = loss of fluid and electrolytes •Proteolytic activity of intestinal enzymes requires: •In small wounds with low output fistula barrier and keeping skin dry •Large abdominal wall defects with high output fistulas treatment with wound bags and sump suction drainage •No vacuum devices on exposed bowel •Proton pump inhibitors to diminish gastric secretion •No significant effects of Somatostatin analogues •Motility inhibitors (Imodium, Loperamide)
  • 42. Wound care (of another patient) • Daily inspection and care • Stoma / wound care nurses Day 0 Day 0 Day 7 Day 49
  • 44. Spontaneous closure Overall spontaneous closure rate 20-30% •Usually occurs within 30 days after development of the fistula •When spontaneous closure does not occur surgical treatment is generally needed Negative predictors for spontaneous closure • Major dehiscence of the anastomosis • Short fistula tract • Distal obstruction • Epithelialised fistula tract • Sepsis or nearby abscess cavity • High output ECF • Chronic ECF • Fistula in an open abdominal wound • Non-surgical cause • Referrals • Jejuno-ileal ECF
  • 45. SOWATS: Timing of surgery •Wait at least 6-12 weeks before performing restorative surgery to allow the abdomen to become accessible again •Sepsis should be controlled •Dry, loss of edema, wrinkling of the skin •Biochemical parameters (albumin > > 25 g/L) •Adequate nutritional status •Clinical parameters (muscle, immune, cognition)
  • 46. SOWATS: Surgical closure •Performed in 60-80% of patients •Successful in 85-90% of cases in centers •45-70% of the overall closure rate •Resection of fistula tract and diseased bowel •Reconnection of the intestine •Sutures surrounded by healthy tissue, not exposed to other suture lines or wound closure •Closure of the abdominal wall with fascia or Vicryl mesh
  • 47. Overview reviewed/ treated series 0 10 20 30 40 50 60 70 80 90 100 '46-'59 '60-'70 '70-'75 '77-'87 '90-'05 reviewed period %patients mortality overall closure rate (%) Edmunds, Williams, Welch: Ann. Surg. 1960 Soeters, Fischer, Franklin: Arch. Chir. Neerl. 1977 Soeters, Ebeid, Fischer: Ann. Surg. 1979 Rinsema, Gouma, von Meyenfeldt, van der Linden, Soeters: Acta Chir. Scand. 1990 Visscher, Olde Damink, Winkens, Soeters, van Gemert: Ann. Surg. 2008 157 119 404 114 135
  • 48. 9 days after operation the following lab parameters are found: • Hb 5.6 mmol/L • ESR 36 mm/first hour • Leucocytes 18/ fliter • CRP 115 mg/l • Kreat 120 mol/l • Albumin 15 g/l • BUN 9 mmol/l • Electrolytes • Na 128 mmol/l • K 5.6 mmol/l • Cl 115 mmol • Liver enzymes • AF and GTP Slightly elevated • Transaminases normal • Bilirubin 19 μmol/l • Ca 1.7 mmol/l • Mg 0.41 mmol/l • Zn 7 mol/l • Cu 39 mol/l • Fe 8 mol/l • Transferrin 2.80 mmol/l • Triglycerides 2.3 mmol/l
  • 49. Conclusion •Patients with abdominal catastrophe/ enterocutaneous fistula suffer from multiple complications •Treatment is complex and requires multidisciplinary expertise •SOWATS approach is necessary •Consider nutritional and metabolic complications •Treat sepsis, institute nutrition and physiotherapy: are crucial elements of treatment •Timing and art of surgery are also important •One captain and one deputy captain on the ship